Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Bristol Myers Squibb Company (BMY) had Stock-Based Compensation of $507.00M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$12.34B |
|
$72.00M |
|
$4.81B |
|
$7.53B |
|
$12.17B |
|
$175.00M |
|
-- |
|
$175.00M |
|
$175.00M |
|
$76.00M |
|
$76.00M |
|
$76.00M |
|
$76.00M |
|
$175.00M |
|
$2.06B |
|
2.03B |
|
2.03B |
|
$0.05 |
|
$0.05 |
|
| Balance Sheet Financials | |
$29.78B |
|
$7.14B |
|
$62.82B |
|
$92.60B |
|
$23.77B |
|
$47.60B |
|
$52.44B |
|
$76.22B |
|
$16.39B |
|
$-28.64B |
|
$16.39B |
|
2.01B |
|
| Cash Flow Statement Financials | |
$15.19B |
|
$-21.35B |
|
$5.13B |
|
$11.52B |
|
$10.35B |
|
$-1.17B |
|
|
Stock-Based Compensation |
$507.00M |
$-4.86B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.25 |
|
-- |
|
-- |
|
0.74 |
|
3.03 |
|
61.01% |
|
1.42% |
|
1.42% |
|
-- |
|
1.42% |
|
0.58% |
|
$13.94B |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
1.88 |
|
1.15 |
|
78.37 |
|
0.46% |
|
-0.27% |
|
0.08% |
|
0.12% |
|
$8.17 |
|
$6.88 |
|
$7.49 |
|